Recent advances in the study of (–)clausenamide: chemistry, biological activities and mechanism of action
Clausenamide (clau) is one of seven novel compounds isolated from Clausena lansium (Lour) skeels. Clau is unusual in that it contains 4 chiral centers yielding 8 pairs of enantiomers. After identification of the configuration of these enantiomers, the synthesis of 16 enantiomers, including optically...
Main Authors: | Shi-feng Chu, Jun-tian Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2014-12-01
|
Series: | Acta Pharmaceutica Sinica B |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211383514001038 |
Similar Items
-
Truncated tau deregulates synaptic markers in rat model for human tauopathy
by: Santosh eJadhav, et al.
Published: (2015-02-01) -
Alzheimer’s disease brain contains tau fractions with differential prion-like activities
by: Longfei Li, et al.
Published: (2021-02-01) -
LTP and memory impairment caused by extracellular Aβ and Tau oligomers is APP-dependent
by: Daniela Puzzo, et al.
Published: (2017-07-01) -
Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau
by: Niklas Mattsson‐Carlgren, et al.
Published: (2021-06-01) -
The Neuronal Actions of Leptin and the Implications for Treating Alzheimer’s Disease
by: Kirsty Hamilton, et al.
Published: (2021-01-01)